Specialized Modalities

Modality Leadership

Established experience in Cell & Gene (25+ years), mRNA (5+ years), and Microbial (30+ years)

450+ Process Development Projects:

Proven track record transforming cutting-edge science into scalable, advanced manufacturing – backed by modern, purpose-built facilities

16 Pre-Licensing Inspections (PLIs) Passed:

Regulatory confidence at every stage, with deep expertise in bringing products to market

Specialized Modalities

Contract Development Manufacturing Services

Cell & Gene

Established expertise accelerating your path to IND and beyond to commercialize and deliver cell and gene therapies

Learn more

mRNA/LNP

Benefit from our end-to-end services for manufacturing and development of mRNA/LNP products

Learn more

Microbial

Scale and futureproof your next-gen biologic with Lonza’s advanced microbial fermentation services

Learn more

Products and Technologies

Bioscience Products

Our products and services range from cell culture and discovery technologies for research to quality control tests and software for biomanufacturing

Learn more

Cocoon® Platform

The Cocoon® Platform streamlines cell therapy manufacturing resulting in greater efficiency and reliability. Automated, closed, and flexible, this...

Learn more

Related Insights

Visit Knowledge Center

Webinar (on-demand)

Producing Engineered Extracellular Vesicles with a Platform Approach

In this webinar, we'll discuss materials and methods to enable the expression of biomolecules on...

Peer-reviewed publication

Three-Dimensional Linkage Analysis With Digital PCR for Genome Integrity and Identity of Recombinant...

Abstract: Recombinant adeno-associated virus (rAAV) has emerged as the vector of choice for in vivo...

Article

Women In Science Spotlight

Women In Science Spotlight featuring Inbar Friedrich Ben-Nun, Director of R&D, Lonza Cell & Gene...

Video

CAR-T Cells on the Fast Lane: From T-cell Selection to CAR-T Cell Drug Product in Just 3 Days

In this presentation, we explore the rapid growth of the CAR T market, driven by oncology...

Article

An interview with Lisa Prendergast for Next Generation Gene Therapy Vectors Conference

Dr. Lisa Prendergast leads innovation for Lonza's Licensing Business Unit, supporting the growth of...

Houston, TX facility,Woman working in lab,PD scientist in lab,CGT Houston Process Development

Technical/Service brief

Translating Exosome Candidates into Approved Therapies with engEx® Platform Technologies

Exosomes represent one type of extracellular vesicle (EV) generated by all eukaryotic cells....

Technical/Service brief

Cocoon® CAR-T™: Manufacturing Cell Therapies in the Lonza Cocoon® Platform - 9-day Process

Performance data of the 9-day process for functionally-closed and automated manufacture of...

Webinar (on-demand)

Enhancing CAR-T Therapy Development - Harnessing Cell Selection Flexibility

Abstract: During this webinar, our experts will explore recent developments that highlight the...

Technical/Service brief

GMP Tissue Sourcing

A complex process, prone to misconceptions and pitfalls, to find the “right human tissue” that will...

Visit Knowledge Center